Motonobu Anai

6.4k citations

77 papers · 5.2k indexed · h-index 44

Molecular Biology top 2%
Surgery top 2%
Endocrinology, Diabetes and Metabolism top 1%
Physiology top 2%
Epidemiology top 5%

Co-authors: Tomoichiro Asano Takehide Ogihara Hideki Katagiri Yasushi Fukushima Kouichi Inukai Hideyuki Sakoda Masatoshi Kikuchi Yoshitomo Oka
Topics: Metabolism, Diabetes, and Cancer (33 papers)Pancreatic function and diabetes (23 papers)PI3K/AKT/mTOR signaling in cancer (11 papers)
Cited by: Endocrinology, Diabetes and Metabolism Endocrine and Autonomic Systems Physiology
Journals: The Lancet Journal of Biological Chemistry Diabetes
Partner nations: Japan United States Kenya

In The Last Decade

Motonobu Anai

77 papers receiving 5.1k citations

Peers

Countries citing papers authored by Motonobu Anai

Since Specialization

Citations

This map shows the geographic impact of Motonobu Anai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motonobu Anai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motonobu Anai more than expected).

Fields of papers citing papers by Motonobu Anai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motonobu Anai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motonobu Anai. The network helps show where Motonobu Anai may publish in the future.

Co-authorship network of co-authors of Motonobu Anai

This figure shows the co-authorship network connecting the top 25 collaborators of Motonobu Anai. A scholar is included among the top collaborators of Motonobu Anai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motonobu Anai. Motonobu Anai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gastrin-releasing peptide regulates fear learning under stressed conditions via activation of the amygdalostriatal transition area 2022 ·Molecular Psychiatry ·(unknown),Yuji Kiyama,(unknown),Hiroyuki Okuno,Taeko Ichise,Hirotake Ichise,Motonobu Anai,Tatsuhiko Kodama,Nobuaki Yoshida,Haruhiko Bito,Toshiya Manabe	4
2	Synergistic association of the copper/zinc ratio under inflammatory conditions with diabetic kidney disease in patients with type 2 diabetes: The Asahi Diabetes Complications Study 2021 ·Journal of Diabetes Investigation ·Toshiko Takao,Hiroyuki Yanagisawa,Machi Suka,Yoko Yoshida,Yukiko Onishi,(unknown),Takako Kikuchi,Akifumi Kushiyama,Motonobu Anai,(unknown),(unknown),Hiroki Yamazaki,Shoji Kawazu,Yasuhiko Iwamoto,Mitsuhiko Noda,Masato Kasuga	23
3	Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content 2020 ·Scientific Reports ·Yusuke Sasaki,(unknown),Toshiya Tanaka,Shogo Yamamoto,Kentaro Murakami,(unknown),Yoshihiro Matsumura,Tsuyoshi Osawa,Motonobu Anai,Jean‐Charles Fruchart,Hiroyuki Aburatani,Juro Sakai,Tatsuhiko Kodama	77
4	Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy 2018 ·Diabetes Therapy ·Hisamitsu Ishihara,Motonobu Anai,Hiroaki Seino,(unknown),Hiroshi Ohashi,Masumi Ai,Masahiro Inoue,Midori Fujishiro,(unknown),Hisamoto Kuroda,Masayo Yamada	2
5	Fasting tests of insulin secretion and sensitivity predict future prediabetes in Japanese with normal glucose tolerance 2010 ·Journal of Diabetes Investigation ·Yukiko Onishi,Tomoshige Hayashi,Kyoko Satō,Takehide Ogihara,Nobuaki Kuzuya,Motonobu Anai,Katsunori Tsukuda,Edward J. Boyko,Wilfred Y. Fujimoto,Masatoshi Kikuchi	34
6	Serum concentrations of resistin-like molecules β and γ are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow 2005 ·Diabetologia ·Nobuhiro Shojima,Takehide Ogihara,Kouichi Inukai,Midori Fujishiro,Hideyuki Sakoda,Akifumi Kushiyama,Hideki Katagiri,Motonobu Anai,Hiraku Ono,Yasushi Fukushima,Nanao Horike,Amelia Y.I. Viana,Yasunobu Uchijima,Hiroki Kurihara,Tomoichiro Asano	37
7	Resistin-like Molecule β Activates MAPKs, Suppresses Insulin Signaling in Hepatocytes, and Induces Diabetes, Hyperlipidemia, and Fatty Liver in Transgenic Mice on a High Fat Diet 2005 ·Journal of Biological Chemistry ·Akifumi Kushiyama,Nobuhiro Shojima,Takehide Ogihara,Kouichi Inukai,Hideyuki Sakoda,Midori Fujishiro,Yasushi Fukushima,Motonobu Anai,Hiraku Ono,Nanao Horike,Amelia Y.I. Viana,Yasunobu Uchijima,Koichi Nishiyama,Tatsuo Shimosawa,Toshiro Fujita,Hideki Katagiri,Yoshitomo Oka,Hiroki Kurihara,Tomoichiro Asano	56
8	Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation 2003 ·Biochemical and Biophysical Research Communications ·Yukiko Onishi,(unknown),Takehide Ogihara,Hideyuki Sakoda,Motonobu Anai,Midori Fujishiro,Hiraku Ono,Nobuhiro Shojima,Yasushi Fukushima,Kouichi Inukai,Hideki Katagiri,Masatoshi Kikuchi,Yoshitomo Oka,Tomoichiro Asano	74
9	Potent and Long-Lasting Action of Lafutidine on the Human Histamine H<sub>2</sub> Receptor 2001 ·Digestion ·Yasushi Fukushima,Hiroko Otsuka,(unknown),Tomoichiro Asano,Motonobu Anai,Takao Katsube,Kenji Ogawa,Tetsuro Kajiwara,Shin-ichiro Ohkawa,Takashi Ishikawa,Masao Omata,Toshihito Saitoh	7
10	Five isoforms of the phosphatidylinositol 3‐kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations 2001 ·FEBS Letters ·Kouichi Inukai,Makoto Funaki,Motonobu Anai,Takehide Ogihara,Hideki Katagiri,Yasushi Fukushima,Hideyuki Sakoda,Yukiko Onishi,Hiraku Ono,Midori Fujishiro,Miho Abe,Yoshitomo Oka,(unknown),Tomoichiro Asano	41
11	G649, an allelic variant of the human H2 receptor with low basal activity, is resistant to upregulation upon antagonist exposure 2001 ·The Pharmacogenomics Journal ·Yasushi Fukushima,T. Saitoh,Motonobu Anai,Katsunori Tsukuda,Yukiko Onishi,Hideyuki Sakoda,Kouichi Inukai,Takehide Ogihara,Makoto Funaki,Hiraku Ono,Mitsuhiro Fujishiro,Takashi Ishikawa,R Nagai,Masao Omata,Tomoichiro Asano	7
12	Palmitoylation of the canine histamine H2 receptor occurs at Cys305 and is important for cell surface targeting 2001 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Yasushi Fukushima,Toshihito Saitoh,Motonobu Anai,Takehide Ogihara,Kouichi Inukai,Makoto Funaki,Hideyuki Sakoda,Yukiko Onishi,Hiraku Ono,Midori Fujishiro,Takashi Ishikawa,Kuniaki Takata,Ryozo Nagai,Masao Omata,Tomoichiro Asano	31
13	Antidiabetic effect of T-1095, an inhibitor of Na+-glucose cotransporter, in neonatally streptozotocin-treated rats 2000 ·European Journal of Pharmacology ·Akira Oku,Kiichiro Ueta,Masao Nawano,Kenji Arakawa,(unknown),Mamoru Matsumoto,Akira Saito,Kenji Tsujihara,Motonobu Anai,Tomoichiro Asano	49
14	Hyperglycemia Impairs the Insulin Signaling Step between PI 3-Kinase and Akt/PKB Activations in ZDF Rat Liver 1999 ·Biochemical and Biophysical Research Communications ·Masao Nawano,Kiichiro Ueta,Akira Oku,Kenji Arakawa,Akira Saito,Makoto Funaki,Motonobu Anai,(unknown),Yoshitomo Oka,Tomoichiro Asano	34
15	Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat 1999 ·Metabolism ·Masao Nawano,Motonobu Anai,Makoto Funaki,Hiroyuki Kobayashi,Akira Kanda,(unknown),Kouichi Inukai,Takehide Ogihara,Hideyuki Sakoda,Yukiko Onishi,(unknown),Yoshio Yazaki,Yoshitomo Oka,Tomoichiro Asano	74
16	Different Subcellular Distribution and Regulation of Expression of Insulin Receptor Substrate (IRS)-3 from Those of IRS-1 and IRS-2 1998 ·Journal of Biological Chemistry ·Motonobu Anai,Hiraku Ono,Makoto Funaki,Yasushi Fukushima,Kouichi Inukai,Takehide Ogihara,Hideyuki Sakoda,Yukiko Onishi,Yoshio Yazaki,Masatoshi Kikuchi,Yoshitomo Oka,Tomoichiro Asano	60
17	Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells¹ 1997 ·FEBS Letters ·Yasushi Fukushima,Tomoichiro Asano,Toshihito Saitoh,Motonobu Anai,Makoto Funaki,Takehide Ogihara,Hideki Katagiri,Nobuyuki Matsuhashi,Yoshio Yazaki,Kentaro Sugano	52
18	p85α Gene Generates Three Isoforms of Regulatory Subunit for Phosphatidylinositol 3-Kinase (PI 3-Kinase), p50α, p55α, and p85α, with Different PI 3-Kinase Activity Elevating Responses to Insulin 1997 ·Journal of Biological Chemistry ·Kouichi Inukai,Makoto Funaki,Takehide Ogihara,Hideki Katagiri,Akira Kanda,Motonobu Anai,Yasushi Fukushima,Toshio Hosaka,Masakazu Suzuki,Bo‐Chul Shin,Kuniaki Takata,Yoshio Yazaki,Masatoshi Kikuchi,Yoshitomo Oka,Tomoichiro Asano	132
19	A Novel Isoform of Syntaxin-binding Protein Homologous to Yeast Sec1 Expressed Ubiquitously in Mammalian Cells 1995 ·Journal of Biological Chemistry ·Hideki Katagiri,Jungo Terasaki,Tomiyasu Murata,Hisamitsu Ishihara,Takehide Ogihara,Kouichi Inukai,Yasushi Fukushima,Motonobu Anai,Masatoshi Kikuchi,Jun‐ichi Miyazaki,Yoshio Yazaki,Yoshitomo Oka	66
20	Characterization of rat GLUT5 and functional analysis of chimeric proteins of GLUT1 glucose transporter and GLUT5 fructose transporter. 1995 ·Endocrinology ·Koichi Inukai,Hideki Katagiri,Kei‐ichi Takata,Tomoichiro Asano,Motonobu Anai,Hisamitsu Ishihara,Mitsuhiro Nakazaki,Masayoshi Kikuchi,Y Yazaki,Y. Oka	38

About Motonobu Anai

Motonobu Anai is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 77 papers that have together received 5.2k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (33 papers), Pancreatic function and diabetes (23 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Endocrine and Autonomic Systems (335 citations) and Physiology (1.2k citations). Motonobu Anai has collaborated with scholars based in Japan, United States and Kenya. Frequent co-authors include Tomoichiro Asano, Takehide Ogihara, Hideki Katagiri, Yasushi Fukushima, Kouichi Inukai, Hideyuki Sakoda, Masatoshi Kikuchi, Yoshitomo Oka, Yukiko Onishi and Hiraku Ono. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact